Anika Therapeutics, Inc. — Director's Dealing 2016

Apr 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2016-04-04

Reporting Person: Mascioli Stephen R. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-04	Stock Option (Right to Buy)	$44.54	A	40000	Acquired	2026-04-04	Common Stock (40000)	Direct

Footnotes

F1: The stock options vest in four equal annual installments beginning April 4, 2017.